|
|
THE GROUP |
THE COMPANY |
|||
|
|
Notes |
2022 |
2021 |
2022 |
2021 |
|
|
|
MUR’ 000 |
MUR ’000 |
MUR’ 000 |
MUR ‘000 |
|
Cash flow from financing activities |
|
|
|
|
|
|
Proceeds from borrowings |
|
5,988,408 |
6,947,926 |
- |
504,117 |
|
Repayment of borrowings |
|
(5,409,241) |
(8,561,619) |
- |
(450,000) |
|
Repayments of principal element of leases |
16 |
(239,241) |
(204,389) |
- |
- |
|
Proceeds from convertible bonds |
27(b) |
547,600 |
2,264,792 |
- |
- |
|
Dividends paid to non-controlling interests |
|
(432,474) |
(407,897) |
- |
- |
|
Acquisition of interests in subsidiary company |
12 |
- |
- |
- |
(54,018) |
|
Issue of shares to non-controlling interest |
|
- |
45,797 |
- |
- |
|
Redemption of capital minority stakes (CIEL Heathcare Ltd & CIEL Finance Ltd) |
|
(101,659) |
- |
|
|
|
Dividends paid to parent |
36 |
(84,372) |
- |
(84,372) |
- |
|
Dividends paid to executives |
|
(4,000) |
- |
- |
- |
|
Net cash from/(used in) financing activities |
|
265,021 |
84,610 |
(84,372) |
99 |
|
Increase/(Decrease) in cash and cash equivalents |
|
2,278,642 |
2,239,496 |
138,254 |
(199,648) |
|
Movement in cash and cash equivalents |
|
|
|
|
|
|
At 1 July |
|
9,191,978 |
6,884,244 |
(173,999) |
25,649 |
|
Exchange differences |
|
80,818 |
68,238 |
- |
- |
|
Increase/(decrease) |
|
2,278,642 |
2,239,496 |
138,254 |
(199,648) |
|
At 30 June |
39(b) |
11,551,438 |
9,191,978 |
(35,745) |
(173,999) |